Stay updated with breaking news from Spinethera Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PLYMOUTH, Minn.--(BUSINESS WIRE)--SpineThera, Inc., a leading clinical-stage pharmaceutical company specializing in innovative injectable drugs, is thrilled to announce groundbreaking results from an independent market research study. The study underscores the enormous potential of SpineThera's SX600, a novel formul...
Major players in the chronic lower back pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals Plc., Merck...
/PRNewswire/ -- Allied Market Research published a report, titled, "Sciatica Treatment Market by Type (Acute sciatica, Chronic sciatica, Others), by Drug class...
PLYMOUTH, Minn.--(BUSINESS WIRE)--SpineThera, Inc., a privately held, clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone microspheres for transforaminal epidural injection [TF-EI] for the management of sciatica pain) today announced promis...
VANCOUVER, BC, Oct. 13, 2022 /PRNewswire/ -- Recent study report released by Data Bridge Market research titled "Lower Back Pain Market" guarantees one will remain better informed than the competition.